Loading profile...
Bryan Williams
Bryan Williams is an internationally recognised cancer researcher and research administrator, with significant business experience. He has held a number of governance roles, including with a NASDAQ-listed biotech company. Bryan was Director and CEO of the Hudson Institute of Medical Research in Melbourne. He is currently Emeritus Director and Distinguished Scientist at the Hudson Institute. He presently serves on boards of two Australian and one American privately held biotechnology companies. He is also a co-founder of an American biotechnology company. Bryan has been an Independent Director of Pacific Edge since 2013. He holds a BSc (Hons) and PhD in Microbiology from the University of Otago.
Current Positions
- Member at Auckland Grammar School Headmaster's Council Incorporated (charity)
- Independent Director at Delegat Group Limited (issuer)
- Vice Chair at The Hokitika Branch Of The Royal New Zealand Society For The Prevention Of Cruelty To Animals Incorporated (charity)
- Trustee at Louise Perkins Foundation (charity)
Education
BSc (Hons), PhD (Microbiology), University of Otago
About this profile
This profile aggregates publicly-available information from 6 source registers for the purpose of cross-platform governance and transparency research. Every fact is sourced from one of the public publications listed below; the aggregation, presentation and any analytical observations are published by NZXplorer.
Source registers used on this page
- NZX market announcements and continuous-disclosure filings
- Audited annual reports lodged with NZX
- FMA Disclose Register (substantial product holders, insider trades)
- NZ Companies Office records (Companies Act 1993 §215)
- NZ Government Gazette appointment notices
- Issuer earnings webcasts and investor presentations
If anything on this page is wrong, missing context, or warrants a formal right-of-reply, use the dispute & right-of-reply form. Our editorial floor — what we always remove on request, the search-engine indexing policy, and the Privacy Act access / correction routes — is set out on Data Principles.